WeVote

Bill

Bill

H 1212

An Act relative to emergency insulin access

194th Legislature (2025-2026) Introduced by Natalie Blais and 14 co-sponsors

Bill H 1212 allows pharmacists to dispense insulin in emergencies without a prescription, ensuring timely access for diabetes patients during critical situations.

Accompanied a new draft, see H4944
0
WeVote Research Nonpartisan
Bill Summary · H 1212

Summary of Bill H 1212: An Act Relative to Emergency Insulin Access

Purpose and Intent

Bill H 1212 aims to improve access to insulin for individuals experiencing emergencies where they cannot obtain a prescription from their healthcare provider. The bill recognizes the critical nature of insulin for those with diabetes and seeks to empower pharmacists to dispense insulin under specific emergency circumstances.

Key Provisions

The bill introduces several amendments to existing Massachusetts General Laws, primarily focusing on the role of pharmacists in emergency situations:

  1. Emergency Dispensing by Pharmacists:

    • Pharmacists are authorized to dispense insulin in emergency situations where obtaining a prescription is not feasible.
    • The amount dispensed cannot exceed a 30-day supply, or the standard unit of dispensing if it exceeds 30 days.
    • A pharmacist must use their professional judgment to determine the necessity of the insulin for the patient’s health.
  2. Limitations on Dispensing:

    • A pharmacist may only dispense insulin under these emergency provisions once every six months to the same patient.
  3. Regulatory Oversight:

    • The Commissioner of Public Health is tasked with creating rules and regulations to implement these provisions effectively.
  4. Amendments to Other Sections:

    • The bill amends various sections of the General Laws (chapters 32A, 112, 118E, 175, 176A, 176B, and 176G) to include provisions for emergency insulin dispensing.

Who Would Be Affected

  • Patients with Diabetes: Individuals who rely on insulin for managing their diabetes will benefit from easier access during emergencies.
  • Pharmacists: The bill expands the responsibilities of pharmacists, allowing them to make critical decisions regarding insulin dispensing in urgent situations.
  • Healthcare Providers: The bill may impact how healthcare providers communicate with patients about insulin access and emergency protocols.

Procedural Aspects

  • Introduced: February 27, 2025
  • Hearing Scheduled: The bill is set for a hearing on October 1, 2025, from 10:30 AM to 1:00 PM in room B-1.
  • Committee Referral: The bill has been referred to the Financial Services Committee and has received concurrence from the Senate.

Conclusion

Bill H 1212 represents a significant step towards ensuring that individuals with diabetes have access to essential medication during emergencies. By allowing pharmacists to dispense insulin without a prescription in urgent situations, the bill aims to prevent potential health crises related to insulin shortages. The upcoming hearing will provide an opportunity for stakeholders to discuss the implications and effectiveness of the proposed measures.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.